Although Photodynamic therapy (PDT) with verteporfin has been accepted as an efficient and safe treatment modality for CSC, it has its rate of recurrence with several side effects. PDT Treatment sparing regimens involving reduced dose or fluence protocols have been used, although adequate procedure guidelines are still missing and the factors influencing its long-term post-treatment outcomes are unknown. Central serous chorioretinopathy (CSCR) is a disease in which a serous detachment of the neurosensory retina occurs over an area of leakage from the choriocapillaris through the retinal pigment epithelium (RPE).
Current treatment: The Photodynamic therapy (PDT) PDT with verteporfin has been accepted as an efficient and safe treatment modality for CSC with effect on choroidal permeability reducing choroidal thickness, resolve sub-retinal fluid and reduce the recurrences. But, even after…
